Swedish Chemicals Stock News

Saniona shareholders came into this earnings release already under pressure, with the stock down about 24% over the past three months and closing at SEK11.61 today. The headline this quarter is not revenue, which remained minimal at SEK4.55m, but the deep operating loss of SEK58.26m that frames the market’s worry about how long the current cash pile can support the pipeline. The emotional gap is clear. The share price has drifted lower for weeks, yet Saniona still reports a trailing 12 month...

SmartCraft Group heads into the post earnings session with a stock that has drifted over the past quarter, down about 8% over 90 days and roughly flat over 30 days, even as the business quietly added more subscription heft. The headline from Q2 is clear: annual recurring revenue reached SEK 514m with organic growth of 6.8%, and total recurring revenue now represents 96% of sales. The market has treated SmartCraft like a mildly volatile software stock with a premium P/E. The question now is...

Traders pushed Eolus Aktiebolag to SEK46.60 by Friday’s close after a strong 30-day run, even as the latest quarter landed with a thud on the income statement. The headline is the profit squeeze. Q2 revenue came in at just SEK14 million while the company reported a net loss of SEK60 million, which translated into a very large loss per share for the quarter. So the short term story is a stock that has climbed in recent weeks. The longer term question is how investors weigh that optimism...

InfraCom Group AB (publ) ( NGM:INFRA ), might not be a large cap stock, but it received a lot of attention from a...

As the European markets navigate through global bond sell-offs and inflationary pressures, investors are increasingly focused on companies with strong fundamentals and growth potential. In this context, growth companies with high insider ownership can be particularly appealing, as they often indicate confidence from those closest to the business in its future prospects.

The European market has recently experienced a dip, with the pan-European STOXX Europe 600 Index ending the week down amid global bond sell-offs and inflationary pressures. Despite these challenges, certain investment opportunities remain attractive, particularly in niche areas like penny stocks. Although the term "penny stocks" may seem outdated, these smaller or newer companies can offer significant growth potential when supported by strong financial health.

As European markets face challenges from global bond sell-offs and inflationary pressures, investors are increasingly seeking stability through dividend stocks. In this environment, a good dividend stock is one that offers consistent payouts and demonstrates resilience amid economic uncertainties.

Why the new Canadian Armed Forces agreement matters for Invisio stock Invisio (OM:IVSO) just announced a multi year Standing Offer with the Canadian Armed Forces for tactical hearing protection and communication systems, with a potential value of up to SEK 450 million. The agreement covers all branches of the Canadian Armed Forces and was secured through partner Simex Defence. For investors, the framework structure and call off ordering mechanics are important to understand when evaluating...

Balco Group AB's (STO:BALCO) stock rose 12% last week, but insiders who sold kr581k worth of stock over the last year...

Terranor Group AB (publ) ( STO:TERNOR ) just released its latest quarterly results and things are looking bullish...

Shareholders might have noticed that QleanAir AB (publ) ( STO:QAIR ) filed its second-quarter result this time last...

The market has punished Smart Eye for months, with the stock down roughly 40% over the past quarter, yet Q2 landed with a very different message. Revenue reached SEK140.9 million and trailing twelve month sales are SEK488.8 million, which keeps this driver monitoring specialist in clear growth mode even as losses persist. The latest quarterly loss of SEK27.0 million keeps the story high risk, but the sentiment gap is now stark. Price has been trading as if the balance sheet strain is the...

AlzeCure Pharma shares came into this earnings print on a sharp upswing, with a very large 90 day gain that set expectations high. The stock now trades at a premium P/E of 34.5x, which already prices in a cleaner story than most European pharma peers. The headline this quarter is blunt. AlzeCure moved from repeated quarterly losses to a profitable Q2, with basic earnings per share of 0.70 SEK on total revenue of 97.33 million SEK, and that shift is what is really testing investor conviction...

Systemair stock has been quietly grinding higher, with a 90‑day gain of about 16%, and closed at SEK88 just as the latest earnings landed. The immediate question for you is whether that move already reflects the story or if the results reset the debate. The headline this season is margin power. Net profit margin over the last 12 months reached 6.1% compared with 5.5% a year earlier while earnings grew 11.8% and now sit against a reported P/E of 24x. The rest of this report unpacks what that...

Ambea (OM:AMBEA) is back in focus after its second quarter 2026 report, which combined higher revenue and net income with fresh commentary on ongoing acquisitions and an active pipeline of bolt on deals. Against this backdrop, Ambea’s share price has gained 21.72% over the past month and 25.14% year to date, with the current share price at SEK173.7. A 1 year total shareholder return of 38.74% and a very large 3 year total shareholder return suggest that momentum has been building as investors...

Alleima (OM:ALLEI) is in focus after two closely timed updates. The company extended its long partnership with Airbus around titanium seamless tubes and committed to a SEK 220 million tubing capacity investment in India. These announcements appear to sit alongside a strong recent run in Alleima’s shares, with a 90 day share price return of 42.57% and a year to date share price return of 45.73%, while the 1 year total shareholder return of 79.32% points to strong momentum building rather than...

Cereno Scientific stock has been grinding lower for months, and today investors had to decide whether another biotech loss story deserves a premium P/S of 20.6x. The headline is blunt. Revenue for Q2 2026 landed at SEK52.6 million, yet the company still reported a net loss of SEK30.5 million and remains unprofitable over the past year. For a drug developer with less than one year of cash runway and forecasts pointing to no revenue next year, this earnings print is a sentiment test. The...

Inission stock came into this earnings day with a flat short term story and a mixed quarter on the tape. The price closed at SEK72.20 with only modest gains over the past month and a soft 90 day return, even as the latest report showed Q2 revenue of SEK635.4m and basic earnings per share of SEK1.30. The headline is margin repair. Earnings before interest, tax and amortisation stepped up, profit margins improved on the trailing 12 month view and investors now have to decide whether that slow...

Bravida Holding (OM:BRAV) has just secured two new data center installation contracts in Sweden and Denmark, including an approximately SEK 850 million project in Mälardalen. These wins give investors fresh context for assessing the stock. At a share price of SEK136.4, Bravida Holding has delivered a 90 day share price return of nearly 20% and a year to date share price return of about 54%. The 1 year total shareholder return of roughly 55% points to strong momentum that these new data center...

GomSpace Group stock has climbed 6.5% over the past week, yet still sits roughly 42% lower over three months, which shows how weak sentiment was coming into this earnings report. The headline this quarter is simple: the small-satellite specialist is now putting profit on the table, with Q2 net income of SEK 8.2m on revenue of SEK 112.6m and a trailing P/E of 54.6x that reflects substantial expectations for future execution. Impressed that GomSpace Group is now posting a profit but wary of a...

AI driven cyber threats are moving from theory to boardroom priority, and regulators are paying close attention. That mix of urgency and scrutiny is reshaping where budgets flow and which companies win large security and AI security contracts. For investors, it creates a window where strong cybersecurity and AI security providers could gain share while weaker players struggle. This article examines three stocks exposed to that news and explains why their positioning matters at this point. The...

BioArctic stock comes into this earnings print with a flat month, a weak 7 day stretch and a 90 day slide that has chipped away at recent enthusiasm. The market has cooled on the story just as the Q2 numbers land. The headline is simple. A biotech built on rich Leqembi royalty expectations has just posted a small quarterly loss despite SEK 247.5m in revenue and recurring royalties closing in on SEK 200m per quarter. The main question now is how investors price a profit wobble in a business...

The European stock market has recently experienced some turbulence, with the pan-European STOXX Europe 600 Index ending the week down due to global bond sell-offs and inflationary pressures. In this context, penny stocks—typically smaller or newer companies—continue to present intriguing opportunities for investors seeking growth at a lower cost. Despite being an outdated term, penny stocks remain relevant as they can offer significant potential when supported by strong financials and sound...

While CombinedX AB (publ) ( STO:CX ) shareholders have enjoyed a good week with stock up 10%, they need remain...